In vitro and in vivo activities of multi-target phtalimido-thiazoles on Schistosomiasis mansoni

Eur J Pharm Sci. 2020 Apr 15:146:105236. doi: 10.1016/j.ejps.2020.105236. Epub 2020 Feb 10.

Abstract

Schistosomicidal activity of six phthalimido-thiazoles derivatives with substitutions at the position three of the thiazole ring were analyzed in an experimental model. The substituents biphenyl (2i) and 2- naphthyl (2j) at a concentration of 80 µg/mL caused 100% mortality of the parasite in culture after 24 h and 48 h respectively. An evaluation of ultrastructural parasites showed damage in the tegument, formation of bubbles and partial destruction of the tubercles. The in vivo anti-parasitic activity with the derivate 2i was performed by administering it orally and intraperitoneally in a 400 mg/kg/5days regimen. Decreases in the number of eggs in the gut (45.1%) and a reduction of the percentage of mature (23.7%) and increased unviable (53.8%) eggs were observed. Our results also showed a reduction in the number of recovered worms after treatment with 2i (oral administration: 81, 25%). The results demonstrated that the prototypes which were tested had a significant anti-schistosomal effect against S. mansoni, suggesting that these derivatives are promising candidates for further research into the chemotherapy of schistosomiasis.

Keywords: In vitro; In vivo; Phthalimide; Schistosma; Schistosomiasis; Thiazole.

MeSH terms

  • Animals
  • Antiprotozoal Agents / pharmacology
  • Antiprotozoal Agents / therapeutic use*
  • Female
  • In Vitro Techniques
  • Male
  • Mice
  • Parasite Egg Count
  • Phthalimides / chemistry*
  • Schistosoma mansoni / drug effects*
  • Schistosoma mansoni / isolation & purification
  • Schistosomiasis mansoni / drug therapy*
  • Spectroscopy, Fourier Transform Infrared
  • Thiazoles / chemistry
  • Thiazoles / pharmacology*

Substances

  • Antiprotozoal Agents
  • Phthalimides
  • Thiazoles